Early Treatment of Nevus of Ota in Children is More Effective and Beneficial to Mental Health: Observation on the Efficacy of Q-Switched Ruby Laser in Treating 159 Cases of Nevus of Ota in Children

Dove Press 2024-06-25

Ji-Cong Jiang,* Ying-Wei Wang,* Yu Gao, Qi-Shuang Zhou Department of Dermatology, The Second Affiliated Hospital and Yuying Children’s Hospital of Wenzhou Medical University, Wenzhou, Zhejiang Province, 325027, People’s Republic of China*These authors contributed equally to this workCorrespondence: Qi-Shuang Zhou; Yu Gao, Email 15258672597@163.com; gaoyu0570@sina.comBackground and Objective: Nevus of Ota (NO), also known as “brownish-blue nevus of the palate of the eye”, is a benign dermal pigmentation that increases skin disease. The Q-switched ruby laser is a classic treatment for nevus of Ota in children, but the optimal age for treatment is still controversial. The aim of this study was to investigate the treatment effect of Q-switched ruby laser in children with nevus of Ota at different ages and the effect on psychological health status.Materials and Methods: Children with nevus of Ota treated with Q-switched ruby laser in the Department of Dermatology of the Second Affiliated Hospital of Wenzhou Medical University from June 2015 to June 2019 were retrospectively analysed. And the mental health status was assessed using the CDI scale.Results: In the preschool children group (0– 7 year age), the significant efficacy rates was 93.1%, the average number of treatments was 3.6, and the overall incidence of adverse reactions was 4.7%. The significant efficacy rates in the school-age children group (7– 14 year age) was 90.3%, the average number of treatments was 5.1, and the overall incidence of adverse reactions was 13.7%. The mean post-treatment CDI score in the preschool children group was 10.8, and 9.7% of children exceeding 19 points. The mean pre-treatment CDI score in the school-age children group was 17.3, and 24.6% of children exceeding 19 points. The mean post-treatment CDI score was 13.6 and 15.1% of children exceeded 19 points. The chi-square test for the significant efficacy rate of the two groups showed P> 0.05, wh

Clinical, Cosmetic and Investigational Dermatology; Original Research; info:eu-repo/semantics/article

Open access content. Open access content
info:eu-repo/semantics/openAccess

text/html
English

NZDMP oai:dovepress.com/93820
1452485140

DOVE MEDL PRESS LTD
From OAIster®, provided by the OCLC Cooperative.

edsoai.on1452485140